Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
9.75%
operating margin TTM
13.49%
revenue TTM
11.98 Million
revenue per share TTM
0.67$
valuation ratios | |
|---|---|
| pe ratio | 16.94 |
| peg ratio | 0.05 |
| price to book ratio | 90.09 |
| price to sales ratio | 1.68 |
| enterprise value multiple | 10.65 |
| price fair value | 90.09 |
profitability ratios | |
|---|---|
| gross profit margin | 89.6% |
| operating profit margin | 13.49% |
| pretax profit margin | 10.24% |
| net profit margin | 9.75% |
| return on assets | 10.66% |
| return on equity | -95.9% |
| return on capital employed | 24.03% |
liquidity ratio | |
|---|---|
| current ratio | 2.13 |
| quick ratio | 2.04 |
| cash ratio | 0.90 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 117.48 |
| operating cycle | 202.21 |
| days of payables outstanding | 65.36 |
| cash conversion cycle | 136.85 |
| receivables turnover | 4.31 |
| payables turnover | 5.58 |
| inventory turnover | 3.11 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.37 |
| debt equity ratio | 18.24 |
| long term debt to capitalization | 0.94 |
| total debt to capitalization | 0.95 |
| interest coverage | 3.06 |
| cash flow to debt ratio | 0.52 |
cash flow ratios | |
|---|---|
| free cash flow per share | 1.79 |
| cash per share | 4.40 |
| operating cash flow per share | 1.79 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | 0.52 |
| short term coverage ratios | 4.33 |
| capital expenditure coverage ratio | 874.19 |
Frequently Asked Questions
When was the last time Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) reported earnings?
Rigel Pharmaceuticals, Inc. (RIGL) published its most recent earnings results on 07-11-2024.
What is Rigel Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)'s trailing twelve months ROE is -95.9%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Rigel Pharmaceuticals, Inc. (RIGL) currently has a ROA of 10.66%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did RIGL's net profit margin stand at?
RIGL reported a profit margin of 9.75% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is RIGL's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.13 in the most recent quarter. The quick ratio stood at 2.04, with a Debt/Eq ratio of 18.24.